Micronutrient Deficiencies in Inflammatory Bowel Disease_ From a to Zinc - Hwang - 2012 - Inflammatory Bowel Diseases - Wiley Online Library
Butirric AcTHE ROLE OF BUTYRIC ACID AS A PROTECTIVE AGENT AGAINST INFLAMMATORY BOWEL DISEASESid
Introductions. l To apply knowledge of anatomy in needle placement of injections of the shoulder, knee and foot l To understand the pharmacology of injectates.
Chief’s Conference Herbal Supplements: A to Z Katina Robertson, MD Emory University Family Medicine Program Thursday, January 7, 2010.
1 ACR 2011 Medical Passport Highlights of ACR 2011 Chicago, IL November 2011.
Emerging treatments in Crohn’s disease and ulcerative colitis Athos Bousvaros MD MPH Boston Children’s Hospital.
Positioning Our Recent & Future Therapy in Crohn’s disease Ahmad Alfadhli MD, FRCPC Gastroenterology Unite Haya Al-Habeeb Center Mubarak Al-Kabeer Hospital.
Journey of the depressed patient Dr Acha Okoko MBBS, MSc, DPM, MRCPsych, MSc, LLM, FMCPsych Consultant Psychiatrist.
Q UALITY R EPORTING F OR C OLONOSCOPY I N IBD Gil Y. Melmed, MD, MS Cedars-Sinai Medical Center CCFA Advances in IBD Orlando, FL December 2014.
Current and Evolving Therapy of Crohn’s Disease (CD) Orooj khan MBBS Ali Minhas MBBS Maya Srivastava MD PhD.
ROLE OF RENAL BIOPSY IN SILENT LUPUS NEPHRITIS M.E. Guerra 1, Y. Arce 2, M.M Díaz 3, P. Moya 4. J. Ballarín 3, F. Algaba 5 1 Department of Pathology. Central.
Therapeutic algorithms for Crohn’s disease: Where are we in 2012?
